Daan van den Broek Selected Research

Daan van den Broek Research Topics

Disease

23	Neoplasms (Cancer) 03/2024 - 01/2015
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 01/2015
6	Neoplasm Metastasis (Metastasis) 09/2023 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 08/2021 - 12/2020
2	Ovarian Neoplasms (Ovarian Cancer) 02/2024 - 10/2021
2	Breast Neoplasms (Breast Cancer) 03/2023 - 01/2023
2	Melanoma (Melanoma, Malignant) 01/2023 - 09/2015
2	Malignant Mesothelioma 11/2021 - 03/2016
2	Circulating Neoplastic Cells 09/2021 - 01/2020
2	Heart Failure 09/2015 - 09/2010
2	Chronic Renal Insufficiency 01/2015 - 09/2010
1	Squamous Cell Carcinoma of Head and Neck 09/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2023
1	Brain Neoplasms (Brain Tumor) 03/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Residual Neoplasm 01/2022
1	Disease Progression 01/2022
1	Triple Negative Breast Neoplasms 12/2021
1	Sarcoma (Soft Tissue Sarcoma) 05/2020
1	Hemolysis 09/2019
1	Pleural Effusion (Pleural Effusions) 02/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2017
1	Hepatorenal Syndrome 03/2016
1	Acute Liver Failure (Fulminant Hepatic Failure) 03/2016
1	Necrosis 03/2016
1	Hepatic Encephalopathy 03/2016
1	Cytokine Release Syndrome 09/2015
1	Renal Insufficiency (Renal Failure) 09/2010
1	Inflammation (Inflammations) 09/2010

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 02/2024 - 03/2016
9	Circulating Tumor DNAIBA 03/2024 - 01/2020
8	Cell-Free Nucleic AcidsIBA 02/2024 - 02/2019
6	DNA (Deoxyribonucleic Acid)IBA 03/2023 - 01/2020
5	tetraethylpyrazine (TEP)IBA 01/2023 - 01/2017
4	NivolumabIBA 07/2023 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2016
3	Tyrosine Kinase InhibitorsIBA 10/2023 - 02/2019
3	ErbB Receptors (EGF Receptor)IBA 10/2023 - 12/2020
3	RNA (Ribonucleic Acid)IBA 05/2023 - 05/2020
2	AntigensIBA 02/2024 - 10/2021
2	IpilimumabIBA 07/2023 - 01/2023
2	Messenger RNA (mRNA)IBA 05/2023 - 01/2023
2	Bevacizumab (Avastin)FDA Link 12/2021 - 01/2021
1	Cetuximab (Erbitux)FDA Link 10/2023
1	AfatinibIBA 10/2023
1	squamous cell carcinoma-related antigenIBA 09/2023
1	Tumor Biomarkers (Tumor Markers)IBA 09/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	pembrolizumabIBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2021
1	Carboplatin (JM8)FDA LinkGeneric 12/2021
1	antigen CYFRA21.1IBA 11/2021
1	Cytidine Monophosphate (CMP)IBA 01/2021
1	AntibodiesIBA 12/2020
1	osimertinibIBA 01/2020
1	Epithelial Cell Adhesion MoleculeIBA 01/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2019
1	Serotonin (5 Hydroxytryptamine)IBA 06/2017
1	Cysteine (L-Cysteine)FDA Link 03/2016
1	BilirubinIBA 03/2016
1	CrizotinibIBA 03/2016
1	Interleukin-6 (Interleukin 6)IBA 09/2015
1	C-Reactive ProteinIBA 09/2015
1	EpitopesIBA 09/2015
1	CytokinesIBA 09/2015
1	ProcalcitoninIBA 09/2015
1	HLA-A*02:01 antigenIBA 09/2015
1	pro-brain natriuretic peptide (1-76)IBA 09/2015
1	pro-gastrin-releasing peptide (31-98)IBA 01/2015
1	IronIBA 09/2010
1	Erythropoietin FDA Link 09/2010
1	HepcidinsIBA 09/2010

Therapy/Procedure

4	Immunotherapy 05/2023 - 01/2021
3	Therapeutics 03/2023 - 03/2016
2	Drug Therapy (Chemotherapy) 12/2021 - 01/2021
1	Adjuvant Chemotherapy 01/2022
1	Aftercare (After-Treatment) 03/2016